title: Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies.
authors.affiliation: Department of Medical Oncology, Fudan University Shanghai Cancer Center, PR China. fudanlijin@163.com
authors.forename: Jin
authors.initials: J
authors.lastname: Li
authors.forename: Xinmin
authors.initials: X
authors.lastname: Zhao
authors.forename: Lei
authors.initials: L
authors.lastname: Chen
authors.forename: Haiyi
authors.initials: H
authors.lastname: Guo
authors.forename: Fangfang
authors.initials: F
authors.lastname: Lv
authors.forename: Ka
authors.initials: K
authors.lastname: Jia
authors.forename: Ke
authors.initials: K
authors.lastname: Yv
authors.forename: Fengqing
authors.initials: F
authors.lastname: Wang
authors.forename: Chuan
authors.initials: C
authors.lastname: Li
authors.forename: Jun
authors.initials: J
authors.lastname: Qian
authors.forename: Chunlei
authors.initials: C
authors.lastname: Zheng
authors.forename: Yunxia
authors.initials: Y
authors.lastname: Zuo